|
Market Closed -
Nasdaq Helsinki
12:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 79.40 EUR | +0.13% |
|
+0.51% | +25.43% |
| 08-27 | Orion launches share buyback for incentive program | FW |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
Company Valuation: Orion Oyj
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,119 | 7,179 | 5,509 | 6,005 | 8,944 | 11,234 | - | - |
| Change | - | 40.25% | -23.26% | 8.99% | 48.95% | 25.6% | - | - |
| Enterprise Value (EV) 1 | 5,010 | 7,060 | 5,603 | 6,126 | 9,088 | 11,144 | 10,901 | 10,631 |
| Change | - | 40.91% | -20.65% | 9.35% | 48.35% | 22.62% | -2.18% | -2.48% |
| P/E | 26.5x | 20.6x | 25.5x | 18.2x | 17.9x | 19.9x | 17x | 15.1x |
| PBR | 6.86x | 7.91x | 6.19x | 5.98x | 6.97x | 7x | 5.64x | 4.62x |
| PEG | - | 0.3x | -0.7x | 0.3x | 0.3x | 1.6x | 1x | 1.2x |
| Capitalization / Revenue | 4.92x | 5.36x | 4.63x | 3.89x | 4.73x | 5.36x | 4.75x | 4.39x |
| EV / Revenue | 4.81x | 5.27x | 4.71x | 3.97x | 4.81x | 5.32x | 4.61x | 4.16x |
| EV / EBITDA | 17.3x | 14.5x | 17.2x | 12x | 13.2x | 14.5x | 12.2x | 10.6x |
| EV / EBIT | 20.6x | 16.1x | 20.4x | 14.7x | 14.4x | 15.7x | 13.2x | 11.4x |
| EV / FCF | 38.5x | 21.7x | 105x | 29.7x | 41.5x | 22.6x | 21.1x | 16.9x |
| FCF Yield | 2.6% | 4.6% | 0.95% | 3.37% | 2.41% | 4.42% | 4.73% | 5.91% |
| Dividend per Share 2 | 1.5 | 1.6 | 1.62 | 1.64 | 1.8 | 1.945 | 2.168 | 2.47 |
| Rate of return | 4.11% | 3.12% | 4.13% | 3.83% | 2.83% | 2.44% | 2.72% | 3.09% |
| EPS 2 | 1.38 | 2.49 | 1.54 | 2.35 | 3.56 | 4.012 | 4.692 | 5.298 |
| Distribution rate | 109% | 64.3% | 105% | 69.8% | 50.6% | 48.5% | 46.2% | 46.6% |
| Net sales 1 | 1,041 | 1,341 | 1,190 | 1,542 | 1,890 | 2,096 | 2,367 | 2,557 |
| EBITDA 1 | 289.1 | 487.1 | 326.4 | 509.4 | 688.3 | 770.8 | 897.2 | 1,002 |
| EBIT 1 | 243.3 | 439.6 | 274.9 | 416.6 | 631.6 | 707.9 | 828.1 | 933.2 |
| Net income 1 | 193.8 | 349.5 | 216.8 | 329.9 | 500.3 | 564.5 | 660.4 | 746.2 |
| Net Debt 1 | -108.3 | -118.7 | 93.3 | 121.7 | 144.4 | -89.76 | -333 | -603.1 |
| Reference price 2 | 36.52 | 51.24 | 39.27 | 42.78 | 63.65 | 79.85 | 79.85 | 79.85 |
| Nbr of stocks (in thousands) | 140,563 | 140,202 | 140,351 | 140,501 | 140,693 | 140,866 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/13/24 | 2/25/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | |
| 29.82x | - | - | 2% | 646B | |
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | |
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | |
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | |
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | |
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 17.17x | 6.58x | 15.74x | 2.38% | 406.59B | |
| Weighted average by Cap. | 24.24x | 8.07x | 17.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORNBV Stock
- ORNAV Stock
- Valuation Orion Oyj
Select your edition
All financial news and data tailored to specific country editions
